Kapiva, the D2C ayurveda brand, has announced the elevation of its Chief Operating Officer (COO) Shantanu and Chief Revenue Officer (CRO) Anuj Sharma to the status of Co-Founders, according to a press release issued on Thursday.
Assuming their new positions, Shantanu will concentrate on evolving the brand into a strategic asset and crafting scientifically supported products, while Anuj’s responsibility will involve incorporating technology to ensure the seamless delivery of comprehensive health results.
Shantanu’s rich expertise encompasses marketing and e-commerce across India, Southeast Asia, and China, gained through roles at companies like Uniqlo and P&G. In a parallel vein, Anuj, an adept leader in driving growth, has applied his skills to notable brands like Myntra and Disney+ Hotstar.
“Shantanu and Anuj have contributed enormously to Kapiva’s journey in the past 2 years. Their expertise and experience have shaped the brand’s growth trajectory quadrupling the brand’s sales in the last 2 years,” commented Ameve Sharma, Co-Founder, Kapiva.
Shantanu, Co-Founder of Kapiva (Formerly COO), expressed, “Kapiva is one of the fastest-growing startups in the country. I am thrilled to be part of its journey and contribute to its success. I believe Ayurveda has the potential to positively impact lives, similar to the way Yoga has worldwide. We are gearing up to reshape the narrative of Ayurveda.”
“We are entering an exciting phase in an industry that is shaping the future. I am immensely thrilled to join visionaries Ameve and Shantanu on this journey. Together, we can empower global consumers with holistic and contemporary solutions, and align with the government’s vision to position India on the global stage by elevating Ayurveda as a significant export,” added Anuj Sharma, Co-Founder, Kapiva (Formerly CRO).
Kapiva was founded in 2016 by Ameve and Shrey Badhani. In 2021, the brand forged a partnership with Bollywood actress Malaika Arora, who became both an investor and a brand ambassador.
As per industry reports, the Ayurveda market is anticipated to undergo a USD 6.81 billion expansion from 2021 to 2026, showcasing a Compound Annual Growth Rate (CAGR) of 15.32 percent.
